Screener
Boundless Bio, Inc. BOLD Q2 2026 earnings
Reported August 4, 2026 · Before market open
EPS-$1.06In line
EPS estimate-$1.06
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.56
Versus estimates
FAQ
- When did Boundless Bio, Inc. report Q2 2026 earnings?
- Boundless Bio, Inc. (BOLD) reported Q2 2026 earnings on August 4, 2026 before market open.
- What were Boundless Bio, Inc.'s Q2 2026 revenue and EPS?
- Boundless Bio, Inc. reported eps of $-1.06 for Q2 2026.
- Did Boundless Bio, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-1.06 by $0.00.
- How did Boundless Bio, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 51.4% from $-0.70.
- Where can I find Boundless Bio, Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-339093) directly on SEC EDGAR. The filing index links above go to sec.gov.
